Lipid Metabolism Disorders
1
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
TakedaTOKYO, Japan
1 programNatural History Study of Children With Metachromatic LeukodystrophyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Frontera TherapeuticsYerba mate consumption
AbbVieCoolSculpting® System
TakedaNatural History Study of Children With Metachromatic Leukodystrophy
Clinical Trials (3)
Total enrollment: 211 patients across 3 trials
Effect of Ilex Paraguariensis Harvest Time and Consumption Method of Processed Yerba Mate on the Lipid Profile
Start: Feb 2026Est. completion: Oct 2026198 patients
N/ARecruiting
Study of White Adipose Tissue Remodeling by Cryolipolysis in Humans
Start: Apr 2021Est. completion: Mar 202212 patients
N/AUnknown
Natural History Study of Children With Metachromatic Leukodystrophy
Start: Nov 2015Est. completion: Apr 20161 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 211 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.